158:@0.085199:0.957873:0.109688:0.957873:0.109688:0.938882:0.085199:0.938882:0.007305:0.008593:0.008591
6:@0.038824:0.497523:0.060302:0.497523:0.060302:0.450045:0.038824:0.450045:0.021478
CHAPTER 6:@0.117647:0.067219:0.190817:0.067219:0.190817:0.047140:0.117647:0.047140:0.009172:0.009650:0.008799:0.008861:0.007388:0.007906:0.009359:0.003320:0.008716
IGK, IGL, TRA, and TRG loci, only V to J recombinations take place as these lack D segments. The evolved :@0.117647:0.118163:0.856447:0.118163:0.856447:0.101494:0.117647:0.101494:0.005584:0.012831:0.011897:0.003679:0.003549:0.005584:0.012831:0.009506:0.003679:0.003549:0.010926:0.011167:0.012214:0.003679:0.003549:0.007433:0.009488:0.009320:0.003549:0.010926:0.010888:0.012831:0.003549:0.004240:0.009226:0.007359:0.004370:0.003679:0.003549:0.008871:0.009712:0.004240:0.007956:0.003549:0.012345:0.003549:0.005080:0.009039:0.003549:0.005622:0.003549:0.006089:0.007452:0.007359:0.008871:0.014231:0.008853:0.004594:0.009562:0.007209:0.005267:0.004538:0.008871:0.009506:0.006275:0.003549:0.005360:0.007695:0.008404:0.007396:0.003549:0.009133:0.004445:0.007601:0.007359:0.007396:0.003549:0.007601:0.006275:0.003549:0.005414:0.009247:0.007396:0.006442:0.007396:0.003549:0.004445:0.007601:0.007172:0.008610:0.003549:0.013204:0.003549:0.006443:0.007396:0.008068:0.014306:0.007396:0.009320:0.005267:0.006275:0.003679:0.003549:0.009385:0.009254:0.007396:0.003549:0.007639:0.007881:0.008946:0.004240:0.007881:0.007452:0.009320:0.003362
V(D)J configuration including the random nucleotide insertions and deletions presents specific genomic :@0.117647:0.132715:0.856318:0.132715:0.856318:0.116046:0.117647:0.116046:0.012345:0.005678:0.013204:0.005678:0.005622:0.004987:0.007359:0.008871:0.009618:0.004650:0.004650:0.008068:0.009338:0.006460:0.007209:0.005267:0.004538:0.008871:0.009618:0.004987:0.004594:0.009488:0.007172:0.004015:0.009282:0.009320:0.004594:0.009376:0.008068:0.004987:0.005416:0.009245:0.007396:0.004987:0.006462:0.007433:0.009488:0.009264:0.008871:0.014437:0.004987:0.009321:0.009282:0.007172:0.004240:0.007452:0.008853:0.005267:0.004537:0.009265:0.007396:0.004987:0.004594:0.009506:0.006443:0.007396:0.006516:0.005267:0.004538:0.008871:0.009506:0.006275:0.004987:0.007433:0.009488:0.009320:0.004987:0.009264:0.007321:0.004240:0.007471:0.005267:0.004538:0.008871:0.009506:0.006275:0.004987:0.009058:0.006089:0.007396:0.006443:0.007396:0.009320:0.005267:0.006275:0.004987:0.006145:0.009413:0.007452:0.007359:0.004594:0.004650:0.004594:0.007359:0.004987:0.007900:0.007396:0.009488:0.008871:0.014437:0.004538:0.007359:0.003362
breakpoint junctions. :@0.117647:0.147267:0.270925:0.147267:0.270925:0.130598:0.117647:0.130598:0.008853:0.006089:0.007601:0.007695:0.008404:0.009413:0.008871:0.004594:0.009320:0.005267:0.005341:0.004053:0.009338:0.009488:0.007452:0.005267:0.004538:0.008871:0.009506:0.006275:0.003679:0.003362
(B):@0.272890:0.147267:0.296628:0.147267:0.296628:0.129977:0.272890:0.129977:0.006238:0.011262:0.006238
 Primers spanning the newly formed breakpoint junction (black) or specific to :@0.296628:0.147267:0.856378:0.147267:0.856378:0.130598:0.296628:0.130598:0.005341:0.009749:0.006387:0.004594:0.014306:0.007396:0.006238:0.006275:0.005341:0.006145:0.009299:0.007435:0.009618:0.009618:0.004594:0.009376:0.008068:0.005341:0.005416:0.009245:0.007396:0.005341:0.009490:0.007637:0.012102:0.004240:0.007956:0.005341:0.004931:0.008873:0.006387:0.014304:0.007452:0.009320:0.005341:0.008853:0.006089:0.007599:0.007695:0.008404:0.009413:0.008871:0.004594:0.009320:0.005267:0.005341:0.004053:0.009338:0.009488:0.007452:0.005267:0.004537:0.008873:0.009618:0.005341:0.005678:0.008927:0.004445:0.007601:0.007172:0.008610:0.005678:0.005341:0.008871:0.006387:0.005341:0.006145:0.009413:0.007452:0.007359:0.004594:0.004650:0.004594:0.007359:0.005341:0.005080:0.009039:0.003362
the breakpoint junction (grey) can be designed and will only yield a positive PCR result in the case of a :@0.117647:0.161819:0.856239:0.161819:0.856239:0.145151:0.117647:0.145151:0.005416:0.009245:0.007396:0.005211:0.008853:0.006089:0.007601:0.007695:0.008404:0.009411:0.008871:0.004594:0.009320:0.005267:0.005211:0.004053:0.009338:0.009488:0.007452:0.005267:0.004538:0.008871:0.009618:0.005211:0.005678:0.008068:0.006089:0.007639:0.007956:0.005678:0.005211:0.007452:0.007433:0.009618:0.005211:0.009207:0.007396:0.005211:0.009264:0.007396:0.006221:0.004594:0.008068:0.009488:0.007450:0.009320:0.005211:0.007433:0.009488:0.009320:0.005211:0.012046:0.004706:0.004408:0.004296:0.005211:0.008871:0.009712:0.004240:0.007956:0.005211:0.007956:0.004538:0.007321:0.004240:0.009320:0.005211:0.007601:0.005211:0.009411:0.008965:0.006219:0.004314:0.005267:0.004538:0.007881:0.007396:0.005211:0.009955:0.012009:0.010944:0.005211:0.006089:0.007396:0.006145:0.009450:0.004015:0.005267:0.005211:0.004594:0.009618:0.005211:0.005416:0.009245:0.007396:0.005211:0.007452:0.007601:0.006442:0.007396:0.005211:0.008871:0.005080:0.005211:0.007601:0.003362
rearrangement. Schematic depiction of the :@0.117647:0.176371:0.416132:0.176371:0.416132:0.159702:0.117647:0.159702:0.006089:0.007601:0.007433:0.006387:0.006462:0.007433:0.009376:0.007900:0.007396:0.014306:0.007396:0.009320:0.005267:0.003679:0.003941:0.008666:0.007172:0.009245:0.007396:0.014381:0.007209:0.005267:0.004538:0.007359:0.003941:0.009264:0.007471:0.009058:0.004538:0.007450:0.005267:0.004538:0.008871:0.009618:0.003941:0.008871:0.005080:0.003941:0.005416:0.009245:0.007396:0.003362
(C):@0.416740:0.176371:0.441299:0.176371:0.441299:0.159081:0.416740:0.159081:0.006238:0.012084:0.006238
 IGH :@0.441299:0.176371:0.480800:0.176371:0.480800:0.159702:0.441299:0.159702:0.003941:0.005584:0.012831:0.013783:0.003362
(D) :@0.481389:0.176371:0.510674:0.176371:0.510674:0.159081:0.481389:0.159081:0.006238:0.013522:0.006238:0.003287
two possible genomic events of IGK, :@0.511245:0.176371:0.768065:0.176371:0.768065:0.159702:0.511245:0.159702:0.005267:0.011878:0.009039:0.003941:0.009411:0.008965:0.006165:0.006219:0.004538:0.008925:0.004240:0.007396:0.003941:0.007900:0.007396:0.009488:0.008873:0.014437:0.004538:0.007359:0.003941:0.007639:0.007881:0.007396:0.009320:0.005267:0.006275:0.003941:0.008871:0.005080:0.003941:0.005584:0.012831:0.011897:0.003679:0.003362
(E) :@0.768675:0.176371:0.794617:0.176371:0.794617:0.159081:0.768675:0.159081:0.006238:0.010179:0.006238:0.003287
IGL, :@0.795189:0.176371:0.830151:0.176371:0.830151:0.159702:0.795189:0.159702:0.005584:0.012831:0.009506:0.003679:0.003362
(F):@0.830735:0.176371:0.852941:0.176371:0.852941:0.159081:0.830735:0.159081:0.006238:0.009730:0.006238
 :@0.852941:0.176371:0.856303:0.176371:0.856303:0.159702:0.852941:0.159702:0.003362
TRA, :@0.117647:0.190923:0.158997:0.190923:0.158997:0.174255:0.117647:0.174255:0.010926:0.011169:0.012214:0.003679:0.003362
(G):@0.158409:0.190923:0.183902:0.190923:0.183902:0.173633:0.158409:0.173633:0.006238:0.013017:0.006238
 TRB,:@0.183902:0.190923:0.222093:0.190923:0.222093:0.174255:0.183902:0.174255:0.002783:0.010926:0.010944:0.009859:0.003679
 (H):@0.222087:0.190923:0.251203:0.190923:0.251203:0.173633:0.222087:0.173633:0.002708:0.006238:0.013933:0.006238
 TRD, and :@0.251208:0.190923:0.324287:0.190923:0.324287:0.174255:0.251208:0.174255:0.002783:0.010926:0.010944:0.012362:0.003679:0.002783:0.007433:0.009488:0.009320:0.003362
(I) :@0.323684:0.190923:0.345965:0.190923:0.345965:0.173633:0.323684:0.173633:0.006238:0.006518:0.006238:0.003287
TRG. J gene segments are boxed. Scissors indicate where the crRNAs target :@0.345391:0.190923:0.856349:0.190923:0.856349:0.174255:0.345391:0.174255:0.010926:0.010888:0.012831:0.003679:0.002783:0.005622:0.002773:0.007900:0.007396:0.009488:0.007396:0.002783:0.006442:0.007396:0.008068:0.014308:0.007396:0.009320:0.005267:0.006275:0.002773:0.007433:0.006089:0.007396:0.002783:0.009206:0.008855:0.008085:0.007452:0.009095:0.003679:0.002783:0.008666:0.007359:0.004594:0.006163:0.006442:0.008873:0.006238:0.006275:0.002773:0.004594:0.009488:0.009320:0.004538:0.007452:0.007209:0.005080:0.007396:0.002773:0.012102:0.009245:0.007396:0.006089:0.007396:0.002783:0.005416:0.009245:0.007396:0.002773:0.007359:0.006387:0.010944:0.012607:0.011934:0.006275:0.002783:0.005360:0.007433:0.006238:0.007900:0.007471:0.005267:0.003362
Cas9 to cut and arrows indicate the desired sequencing direction. Genomic regions are not scaled. :@0.117647:0.205476:0.790909:0.205476:0.790909:0.188807:0.117647:0.188807:0.012252:0.007601:0.006275:0.008535:0.003362:0.005078:0.009039:0.003362:0.007452:0.009058:0.005267:0.003362:0.007433:0.009488:0.009320:0.003362:0.007433:0.006387:0.006089:0.008890:0.012046:0.006275:0.003362:0.004594:0.009488:0.009320:0.004538:0.007452:0.007209:0.005080:0.007396:0.003362:0.005416:0.009245:0.007396:0.003362:0.009264:0.007396:0.006219:0.004594:0.006089:0.007452:0.009320:0.003362:0.006442:0.007452:0.008759:0.009282:0.007396:0.009488:0.007359:0.004594:0.009376:0.008068:0.003362:0.009320:0.004594:0.006089:0.007452:0.007452:0.005267:0.004538:0.008871:0.009618:0.003679:0.003362:0.012941:0.007396:0.009490:0.008869:0.014437:0.004538:0.007359:0.003362:0.006089:0.007396:0.008068:0.004538:0.008871:0.009506:0.006275:0.003362:0.007433:0.006089:0.007396:0.003362:0.009488:0.008853:0.005267:0.003362:0.006443:0.007452:0.007695:0.004240:0.007452:0.009095:0.003679:0.003362
To validate that we can perform targeted sequencing of multiple Ig and TCR loci, we :@0.117647:0.244813:0.857155:0.244813:0.857155:0.224440:0.117647:0.224440:0.010866:0.011048:0.006414:0.009838:0.009405:0.005250:0.005547:0.011571:0.008811:0.006209:0.009039:0.006414:0.006620:0.011391:0.008811:0.006437:0.006414:0.014518:0.009039:0.006414:0.009108:0.009085:0.011756:0.006403:0.011505:0.009039:0.007807:0.006026:0.010843:0.007807:0.017645:0.006414:0.006551:0.009085:0.007624:0.009656:0.009131:0.006209:0.009108:0.011391:0.006403:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.006414:0.010843:0.006209:0.006414:0.017280:0.011550:0.004908:0.006437:0.005273:0.011160:0.005184:0.009039:0.006403:0.006483:0.009861:0.006414:0.009085:0.011596:0.011391:0.006414:0.013057:0.014678:0.013376:0.006414:0.005182:0.011276:0.008994:0.005344:0.004497:0.006414:0.014518:0.009039:0.004109
targeted the ten leukemia samples - in addition to the :@0.117647:0.265392:0.572411:0.265392:0.572411:0.245019:0.117647:0.245019:0.006551:0.009085:0.007624:0.009656:0.009131:0.006209:0.009108:0.011391:0.004634:0.006620:0.011299:0.009039:0.004634:0.006209:0.009039:0.011756:0.004634:0.005182:0.009131:0.011548:0.010274:0.009039:0.017645:0.005796:0.009291:0.004634:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.004634:0.007533:0.004634:0.005615:0.011756:0.004634:0.009291:0.011322:0.011391:0.005271:0.006437:0.005547:0.010845:0.011756:0.004622:0.006209:0.011048:0.004634:0.006620:0.011299:0.009039:0.004109
KMT2A :@0.572854:0.265861:0.652793:0.265861:0.652793:0.243839:0.572854:0.243839:0.014906:0.019996:0.013765:0.010888:0.015157:0.005227
and :@0.653448:0.265392:0.689628:0.265392:0.689628:0.245019:0.653448:0.245019:0.009085:0.011596:0.011391:0.004109
SIL-TAL1 :@0.690144:0.265861:0.783688:0.265861:0.783688:0.243839:0.690144:0.243839:0.010500:0.007647:0.012030:0.007624:0.012326:0.015157:0.012144:0.010888:0.005227
loci - si-:@0.784344:0.265392:0.852941:0.265392:0.852941:0.245019:0.784344:0.245019:0.005182:0.011276:0.008994:0.005615:0.004634:0.007533:0.004634:0.007601:0.005595:0.007533
multaneously with crRNAs for the Ig and TCR loci (:@0.117647:0.285971:0.567421:0.285971:0.567421:0.265598:0.117647:0.265598:0.017280:0.011550:0.004908:0.006551:0.009085:0.011596:0.009108:0.010820:0.011413:0.007556:0.005182:0.009724:0.005547:0.014723:0.005271:0.006620:0.011459:0.005547:0.008994:0.007807:0.013376:0.015408:0.014586:0.007670:0.005547:0.006026:0.010843:0.007807:0.005547:0.006620:0.011299:0.009039:0.005547:0.006483:0.009861:0.005547:0.009085:0.011596:0.011391:0.005547:0.013057:0.014678:0.013376:0.005547:0.005182:0.011274:0.008994:0.005615:0.005547:0.006939
Figure 3C-I and Supplementary :@0.567394:0.285971:0.856959:0.285971:0.856959:0.264838:0.567394:0.264838:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.005419:0.010911:0.014769:0.007213:0.007967:0.005421:0.009656:0.012167:0.011870:0.005419:0.010455:0.011893:0.011733:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.004018
Table 1):@0.117647:0.306549:0.188342:0.306549:0.188342:0.285416:0.117647:0.285416:0.011413:0.009679:0.011528:0.005935:0.009473:0.004132:0.010911:0.007624
. B-ALL1, B-ALL2 and T-ALL1 were targeted with the fusion crRNAs as well as :@0.188334:0.306549:0.857118:0.306549:0.857118:0.286176:0.188334:0.286176:0.004497:0.004223:0.012646:0.007533:0.014929:0.011619:0.011619:0.010432:0.004497:0.004223:0.012646:0.007533:0.014929:0.011619:0.011619:0.010432:0.004223:0.009087:0.011596:0.011391:0.004223:0.011801:0.007533:0.014929:0.011619:0.011619:0.010432:0.004223:0.014518:0.009039:0.007442:0.009039:0.004223:0.006551:0.009085:0.007624:0.009656:0.009131:0.006209:0.009108:0.011391:0.004223:0.014723:0.005273:0.006620:0.011459:0.004223:0.006620:0.011299:0.009039:0.004223:0.006366:0.011413:0.007604:0.005547:0.010843:0.011756:0.004223:0.008994:0.007807:0.013376:0.015410:0.014586:0.007670:0.004223:0.009291:0.007670:0.004223:0.014518:0.008950:0.005385:0.005250:0.004223:0.009291:0.007670:0.004109
the IGH, IGK, IGL, TRB and TRG crRNAs (:@0.117647:0.327128:0.485501:0.327128:0.485501:0.306755:0.117647:0.306755:0.006620:0.011299:0.009039:0.003538:0.006825:0.015682:0.016846:0.004497:0.003538:0.006825:0.015682:0.014541:0.004497:0.003538:0.006825:0.015682:0.011619:0.004497:0.003538:0.013354:0.013376:0.012646:0.003538:0.009085:0.011596:0.011391:0.003538:0.013354:0.013308:0.015682:0.003538:0.008994:0.007807:0.013376:0.015408:0.014586:0.007670:0.003538:0.006939
Supplementary Table 1:@0.485485:0.327128:0.687890:0.327128:0.687890:0.305995:0.485485:0.305995:0.010455:0.011893:0.011733:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.003458:0.011413:0.009679:0.011528:0.005935:0.009473:0.003458:0.010911
). B-ALL3, B-ALL4, :@0.687888:0.327128:0.857057:0.327128:0.857057:0.306755:0.687888:0.306755:0.006939:0.004497:0.003538:0.012646:0.007533:0.014929:0.011619:0.011619:0.010432:0.004497:0.003538:0.012646:0.007533:0.014929:0.011619:0.011619:0.010432:0.004497:0.004109
B-ALL5, T-ALL2, T-ALL3, T-ALL4 and T-ALL5 were additionally targeted with crRNAs :@0.117647:0.347707:0.857121:0.347707:0.857121:0.327334:0.117647:0.327334:0.012646:0.007533:0.014929:0.011619:0.011619:0.010432:0.004497:0.003310:0.011801:0.007533:0.014929:0.011619:0.011619:0.010432:0.004497:0.003310:0.011801:0.007533:0.014929:0.011619:0.011619:0.010432:0.004497:0.003310:0.011801:0.007533:0.014929:0.011619:0.011619:0.010432:0.003310:0.009085:0.011596:0.011391:0.003310:0.011801:0.007533:0.014929:0.011619:0.011619:0.010432:0.003310:0.014518:0.009039:0.007442:0.009039:0.003310:0.009291:0.011322:0.011391:0.005273:0.006437:0.005547:0.010843:0.011687:0.009405:0.005387:0.005182:0.009724:0.003310:0.006551:0.009085:0.007624:0.009656:0.009131:0.006209:0.009108:0.011391:0.003310:0.014723:0.005273:0.006620:0.011459:0.003310:0.008994:0.007807:0.013376:0.015408:0.014586:0.007670:0.004109
for the TRA and TRD loci, a total of 25 crRNAs per sample, providing examples of par-:@0.117647:0.368285:0.852941:0.368285:0.852941:0.347913:0.117647:0.347913:0.006026:0.010843:0.007807:0.004497:0.006620:0.011299:0.009039:0.004497:0.013354:0.013648:0.014929:0.004497:0.009085:0.011596:0.011391:0.004497:0.013354:0.013376:0.016139:0.004497:0.005182:0.011276:0.008994:0.005341:0.004497:0.004497:0.009291:0.004497:0.006209:0.010820:0.006551:0.009402:0.005250:0.004497:0.010843:0.006209:0.004497:0.010432:0.010432:0.004497:0.008994:0.007807:0.013376:0.015408:0.014586:0.007670:0.004497:0.011505:0.009039:0.007807:0.004497:0.007944:0.009085:0.017280:0.011162:0.005182:0.008743:0.004497:0.004497:0.011071:0.007442:0.010866:0.009838:0.005547:0.011391:0.005615:0.011459:0.009861:0.004497:0.009108:0.010089:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.004497:0.010843:0.006209:0.004497:0.011368:0.009085:0.007284:0.007533
allel fusion and comprehensive Ig/TCR sequencing. :@0.117647:0.388864:0.554892:0.388864:0.554892:0.368491:0.117647:0.368491:0.009405:0.005387:0.005182:0.008948:0.005250:0.004109:0.006369:0.011413:0.007601:0.005547:0.010843:0.011756:0.004109:0.009085:0.011596:0.011391:0.004109:0.008994:0.010843:0.017280:0.011071:0.007442:0.008948:0.011299:0.009039:0.011619:0.007601:0.005547:0.009633:0.009039:0.004109:0.006483:0.009861:0.007099:0.013057:0.014678:0.013376:0.004109:0.007873:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009679:0.004497:0.004109
The average per-base coverage for all samples at the different Ig and TCR loci was 0.83x :@0.117647:0.409443:0.856961:0.409443:0.856961:0.389070:0.117647:0.389070:0.011470:0.011311:0.009039:0.004565:0.008925:0.009633:0.009039:0.007898:0.009199:0.009656:0.009039:0.004565:0.011505:0.009039:0.007236:0.007533:0.011117:0.009291:0.007875:0.009039:0.004565:0.008994:0.010863:0.009635:0.009039:0.007896:0.009199:0.009656:0.009039:0.004565:0.006026:0.010843:0.007807:0.004565:0.009405:0.005387:0.005250:0.004565:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.004565:0.008811:0.006437:0.004565:0.006620:0.011299:0.009039:0.004565:0.011391:0.005615:0.005969:0.005787:0.009039:0.007442:0.009039:0.011391:0.006437:0.004565:0.006483:0.009861:0.004565:0.009087:0.011596:0.011391:0.004565:0.013057:0.014678:0.013376:0.004565:0.005182:0.011276:0.008994:0.005615:0.004565:0.014723:0.009291:0.007670:0.004565:0.010432:0.004497:0.010432:0.010432:0.010089:0.004109
(IGH), 0.62x (IGK), 5.97x (IGL), 10.4x (TRA), 3.39x (TRB), 2.77x (TRD), and 10.60x :@0.117647:0.430022:0.857029:0.430022:0.857029:0.409649:0.117647:0.409649:0.006939:0.006825:0.015682:0.016846:0.006939:0.004497:0.006072:0.010432:0.004497:0.010432:0.010432:0.010089:0.006072:0.006939:0.006825:0.015682:0.014541:0.006939:0.004497:0.006072:0.010432:0.004497:0.010432:0.010432:0.010089:0.006072:0.006939:0.006825:0.015682:0.011619:0.006939:0.004497:0.006072:0.010432:0.010432:0.004497:0.010432:0.010089:0.006072:0.006825:0.013354:0.013650:0.014929:0.006939:0.004497:0.006072:0.010432:0.004497:0.010432:0.010432:0.010089:0.006072:0.006825:0.013354:0.013376:0.012646:0.006939:0.004497:0.006072:0.010432:0.004497:0.010432:0.010432:0.010089:0.006072:0.006823:0.013354:0.013376:0.016139:0.006939:0.004497:0.006072:0.009087:0.011596:0.011391:0.006072:0.010432:0.010432:0.004497:0.010432:0.010432:0.010089:0.004109
(TRG) (:@0.117647:0.450600:0.186435:0.450600:0.186435:0.430227:0.117647:0.430227:0.006825:0.013354:0.013308:0.015682:0.006939:0.005741:0.006939
Supplementary Table 1:@0.186436:0.450600:0.393155:0.450600:0.393155:0.429467:0.186436:0.429467:0.010455:0.011893:0.011733:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.005615:0.011413:0.009679:0.011528:0.005935:0.009473:0.005615:0.010911
). We observed a sharp increase of coverage at the cut :@0.393153:0.450600:0.857094:0.450600:0.857094:0.430227:0.393153:0.430227:0.006939:0.004497:0.005741:0.018649:0.009039:0.005752:0.010957:0.010934:0.007875:0.009039:0.008398:0.009635:0.009106:0.011391:0.005752:0.009291:0.005741:0.007556:0.011393:0.009085:0.007964:0.011276:0.005752:0.005615:0.011596:0.008994:0.007442:0.009291:0.009291:0.007875:0.009039:0.005741:0.010843:0.006209:0.005752:0.008994:0.010866:0.009633:0.009039:0.007898:0.009199:0.009656:0.009039:0.005741:0.008811:0.006437:0.005752:0.006620:0.011299:0.009039:0.005741:0.009108:0.011071:0.006437:0.004109
sites (:@0.117647:0.471179:0.164990:0.471179:0.164990:0.450806:0.117647:0.450806:0.007601:0.005273:0.006209:0.009039:0.007670:0.004611:0.006939
Figure 4:@0.164997:0.471179:0.238614:0.471179:0.238614:0.450046:0.164997:0.450046:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.004520:0.010911
). For the IGH, IGK and TRG loci, where we only target with one crRNA :@0.238609:0.471179:0.856941:0.471179:0.856941:0.450806:0.238609:0.450806:0.006939:0.004497:0.004611:0.010683:0.010843:0.007807:0.004611:0.006620:0.011299:0.009039:0.004611:0.006825:0.015682:0.016846:0.004497:0.004611:0.006825:0.015682:0.014541:0.004611:0.009085:0.011596:0.011391:0.004611:0.013354:0.013308:0.015682:0.004611:0.005182:0.011276:0.008994:0.005339:0.004497:0.004611:0.014792:0.011299:0.009039:0.007442:0.009039:0.004611:0.014518:0.009039:0.004611:0.010843:0.011870:0.005182:0.009724:0.004611:0.006551:0.009085:0.007624:0.009656:0.009131:0.006437:0.004611:0.014723:0.005273:0.006620:0.011459:0.004611:0.010845:0.011596:0.009039:0.004611:0.008994:0.007807:0.013376:0.015408:0.014929:0.004109
adjacent to the last J segment or the crRNAs were spaced far apart, we observe reads :@0.117647:0.491758:0.857050:0.491758:0.857050:0.471385:0.117647:0.471385:0.009291:0.011048:0.005273:0.009291:0.008994:0.009039:0.011391:0.006437:0.006446:0.006211:0.011048:0.006446:0.006620:0.011299:0.009039:0.006449:0.005433:0.009291:0.007510:0.006437:0.006449:0.006871:0.006446:0.007875:0.009039:0.009861:0.017485:0.009039:0.011391:0.006437:0.006449:0.010843:0.007807:0.006449:0.006620:0.011299:0.009039:0.006449:0.008994:0.007807:0.013376:0.015408:0.014584:0.007670:0.006449:0.014518:0.009039:0.007442:0.009039:0.006449:0.007510:0.011368:0.009291:0.008994:0.009108:0.011391:0.006446:0.006209:0.009085:0.007807:0.006449:0.008811:0.011368:0.009085:0.007967:0.006437:0.004497:0.006446:0.014520:0.009039:0.006446:0.010957:0.010934:0.007875:0.009039:0.008400:0.009633:0.009039:0.006449:0.007442:0.009288:0.009291:0.011391:0.007670:0.004109
longer than 20 kb (:@0.117647:0.512336:0.279032:0.512336:0.279032:0.491963:0.117647:0.491963:0.005182:0.010843:0.011459:0.009656:0.009039:0.007807:0.004862:0.006620:0.011391:0.009085:0.011756:0.004862:0.010432:0.010432:0.004862:0.010272:0.011025:0.004862:0.006939
Figure 4A-B and F:@0.279054:0.512336:0.443348:0.512336:0.443348:0.491203:0.279054:0.491203:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.004759:0.010911:0.014358:0.007213:0.013765:0.004757:0.009656:0.012167:0.011870:0.004759:0.011893
). Noteworthy, the utilized DNA was not specifi-:@0.443348:0.512336:0.852941:0.512336:0.852941:0.491963:0.443348:0.491963:0.006939:0.004497:0.004862:0.015522:0.010820:0.006209:0.009336:0.014518:0.010843:0.007967:0.006620:0.011071:0.007989:0.004497:0.004862:0.006620:0.011299:0.009039:0.004862:0.011071:0.006437:0.005750:0.005250:0.005615:0.008834:0.009108:0.011391:0.004862:0.015773:0.015408:0.014929:0.004862:0.014723:0.009291:0.007670:0.004862:0.011596:0.010820:0.006437:0.004862:0.007510:0.011505:0.009108:0.008994:0.005615:0.005684:0.005721:0.007533
cally isolated for long-read sequencing approaches, and thus, these read lengths could be :@0.117647:0.532915:0.856981:0.532915:0.856981:0.512542:0.117647:0.512542:0.009108:0.009405:0.005387:0.005182:0.009724:0.003698:0.005615:0.007875:0.010934:0.005433:0.008811:0.006209:0.009108:0.011391:0.003698:0.006024:0.010843:0.007807:0.003698:0.005182:0.010843:0.011459:0.009861:0.007533:0.007442:0.009291:0.009291:0.011391:0.003698:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.003698:0.008811:0.011048:0.011071:0.007442:0.011139:0.009291:0.008765:0.011299:0.009039:0.007670:0.004497:0.003698:0.009085:0.011598:0.011391:0.003698:0.006620:0.011094:0.011413:0.007670:0.004497:0.003698:0.006620:0.011299:0.009039:0.007873:0.009039:0.003698:0.007442:0.009291:0.009291:0.011391:0.003698:0.005182:0.009039:0.011459:0.009861:0.006622:0.011322:0.007670:0.003698:0.008994:0.010820:0.011550:0.005182:0.011391:0.003698:0.011251:0.009039:0.004109
pushed even longer by applying appropriate extraction methods. For the IGK, IGL, TRA, :@0.117647:0.553494:0.857141:0.553494:0.857141:0.533121:0.117647:0.533121:0.011048:0.011413:0.007556:0.011299:0.009108:0.011391:0.003310:0.009336:0.009633:0.009039:0.011756:0.003310:0.005182:0.010843:0.011459:0.009656:0.009039:0.007807:0.003310:0.010843:0.009724:0.003310:0.008811:0.011048:0.011162:0.005182:0.009724:0.005615:0.011459:0.009861:0.003298:0.008813:0.011048:0.011069:0.007442:0.010822:0.011069:0.007807:0.005798:0.008811:0.006209:0.009039:0.003310:0.009108:0.010089:0.006437:0.007898:0.009291:0.009108:0.006437:0.005547:0.010843:0.011756:0.003310:0.017485:0.009131:0.006620:0.011299:0.011276:0.011391:0.007670:0.004497:0.003298:0.010683:0.010843:0.007807:0.003310:0.006620:0.011299:0.009039:0.003310:0.006825:0.015682:0.014541:0.004497:0.003310:0.006825:0.015682:0.011619:0.004497:0.003310:0.013354:0.013648:0.014929:0.004497:0.004109
TRB, TRD and TRG we clearly observe the effectiveness of the tiled crRNA approach to :@0.117647:0.574072:0.857169:0.574072:0.857169:0.553700:0.117647:0.553700:0.013354:0.013376:0.012053:0.004497:0.004246:0.013354:0.013376:0.016139:0.004246:0.009085:0.011596:0.011391:0.004246:0.013354:0.013308:0.015682:0.004246:0.014518:0.009039:0.004246:0.008765:0.005182:0.009291:0.009085:0.007601:0.005182:0.009724:0.004246:0.010957:0.010934:0.007873:0.009039:0.008400:0.009633:0.009039:0.004246:0.006620:0.011299:0.009039:0.004246:0.009039:0.005969:0.005787:0.009108:0.009108:0.006437:0.005547:0.009633:0.009039:0.011596:0.009039:0.007533:0.007670:0.004246:0.010845:0.006209:0.004246:0.006620:0.011299:0.009039:0.004246:0.006437:0.005752:0.005182:0.009108:0.011391:0.004246:0.008994:0.007807:0.013376:0.015410:0.014929:0.004246:0.008811:0.011048:0.011071:0.007442:0.011139:0.009291:0.008765:0.011459:0.004246:0.006209:0.011048:0.004109
cover the entire loci (:@0.117647:0.594651:0.298458:0.594651:0.298458:0.574278:0.117647:0.574278:0.008994:0.010866:0.009633:0.009039:0.007807:0.005136:0.006620:0.011299:0.009039:0.005136:0.009039:0.011391:0.006437:0.005615:0.007442:0.009039:0.005136:0.005182:0.011276:0.008994:0.005615:0.005136:0.006939
Figure 4B-F:@0.298447:0.594651:0.405436:0.594651:0.405436:0.573518:0.298447:0.573518:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.005022:0.010911:0.013765:0.007213:0.011893
). For TRA, we are able to span a 60 kb window with :@0.405432:0.594651:0.857081:0.594651:0.857081:0.574278:0.405432:0.574278:0.006939:0.004497:0.005136:0.010683:0.010843:0.007807:0.005136:0.013354:0.013648:0.014929:0.004497:0.005136:0.014518:0.009039:0.005136:0.009085:0.007442:0.009039:0.005136:0.009108:0.010911:0.005182:0.009039:0.005136:0.006209:0.011048:0.005136:0.007510:0.011368:0.009085:0.011756:0.005136:0.009291:0.005136:0.010432:0.010432:0.005136:0.010272:0.011025:0.005136:0.014723:0.005615:0.011596:0.011322:0.010866:0.014723:0.005136:0.014723:0.005273:0.006620:0.011459:0.004109
eight consecutive crRNAs (:@0.117647:0.615230:0.344431:0.615230:0.344431:0.594857:0.117647:0.594857:0.009039:0.005615:0.009930:0.011094:0.006437:0.003538:0.008994:0.010843:0.011619:0.007875:0.009108:0.009108:0.011071:0.006437:0.005547:0.009633:0.009039:0.003538:0.008994:0.007807:0.013376:0.015408:0.014586:0.007670:0.003538:0.006939
Figure 4D:@0.344433:0.615230:0.433525:0.615230:0.433525:0.594097:0.344433:0.594097:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.003470:0.010911:0.016527
). Visual investigation of the coverage plots already :@0.433516:0.615230:0.857042:0.615230:0.857042:0.594857:0.433516:0.594857:0.006939:0.004497:0.003538:0.014038:0.005615:0.007510:0.011596:0.009405:0.005250:0.003538:0.005615:0.011365:0.009633:0.009039:0.007512:0.006437:0.005615:0.009861:0.008809:0.006437:0.005547:0.010843:0.011756:0.003538:0.010843:0.006209:0.003538:0.006620:0.011299:0.009039:0.003538:0.008994:0.010866:0.009633:0.009039:0.007898:0.009199:0.009656:0.009039:0.003538:0.011162:0.005182:0.010820:0.006437:0.007670:0.003538:0.009405:0.005250:0.007442:0.009291:0.009291:0.011322:0.009724:0.004109
identifies large scale rearrangements events, e.g. by the observed drop in coverage in be-:@0.117647:0.635809:0.852941:0.635809:0.852941:0.615436:0.117647:0.615436:0.005547:0.011322:0.009039:0.011391:0.006437:0.005615:0.005684:0.005615:0.009039:0.007670:0.004269:0.005433:0.009085:0.007624:0.009656:0.009039:0.004269:0.007873:0.009108:0.009405:0.005182:0.009039:0.004269:0.007442:0.009291:0.009085:0.007807:0.007898:0.009085:0.011459:0.009656:0.009039:0.017485:0.009039:0.011391:0.006437:0.007670:0.004269:0.009336:0.009633:0.009039:0.011391:0.006437:0.007670:0.004497:0.004269:0.008743:0.004497:0.009679:0.004497:0.004269:0.010843:0.009724:0.004269:0.006620:0.011299:0.009039:0.004269:0.010957:0.010934:0.007875:0.009039:0.008400:0.009633:0.009108:0.011391:0.004269:0.011391:0.007444:0.010820:0.011276:0.004269:0.005615:0.011756:0.004269:0.008994:0.010866:0.009633:0.009039:0.007898:0.009199:0.009656:0.009039:0.004269:0.005615:0.011756:0.004269:0.011251:0.009154:0.007533
tween crRNA cut-sites (:@0.117647:0.656387:0.318908:0.656387:0.318908:0.636014:0.117647:0.636014:0.006437:0.014518:0.009108:0.009039:0.011756:0.004337:0.008994:0.007807:0.013376:0.015408:0.014929:0.004337:0.009106:0.011071:0.006437:0.007533:0.007601:0.005273:0.006209:0.009039:0.007670:0.004337:0.006939
Figure 4E-F:@0.318891:0.656387:0.423768:0.656387:0.423768:0.635254:0.318891:0.635254:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.004234:0.010911:0.012441:0.007213:0.011893
). The average coverage at the cut-sites in the Ig and :@0.423768:0.656387:0.857114:0.656387:0.857114:0.636014:0.423768:0.636014:0.006939:0.004497:0.004337:0.011470:0.011311:0.009039:0.004337:0.008928:0.009633:0.009039:0.007898:0.009199:0.009656:0.009039:0.004337:0.008994:0.010866:0.009633:0.009039:0.007898:0.009199:0.009656:0.009039:0.004337:0.008811:0.006437:0.004337:0.006620:0.011299:0.009039:0.004337:0.009108:0.011071:0.006437:0.007533:0.007601:0.005273:0.006209:0.009039:0.007670:0.004337:0.005615:0.011756:0.004337:0.006622:0.011297:0.009039:0.004337:0.006483:0.009861:0.004337:0.009085:0.011596:0.011391:0.004109
TCR loci varies from 19x to 230x between the different loci :@0.117647:0.676966:0.626910:0.676966:0.626910:0.656593:0.117647:0.656593:0.013057:0.014678:0.013376:0.005068:0.005182:0.011274:0.008994:0.005615:0.005068:0.009838:0.009085:0.007807:0.005547:0.009039:0.007670:0.005068:0.006412:0.007442:0.010845:0.017645:0.005068:0.010432:0.010432:0.010089:0.005068:0.006209:0.011048:0.005068:0.010432:0.010432:0.010432:0.010089:0.005068:0.011254:0.009131:0.006437:0.014518:0.009108:0.009039:0.011756:0.005068:0.006620:0.011299:0.009039:0.005068:0.011391:0.005615:0.005969:0.005787:0.009039:0.007442:0.009039:0.011391:0.006437:0.005068:0.005184:0.011274:0.008994:0.005615:0.004109
(Supplementary Table 1):@0.627809:0.676966:0.848453:0.676966:0.848453:0.655833:0.627809:0.655833:0.007624:0.010455:0.011893:0.011733:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.004953:0.011413:0.009679:0.011528:0.005935:0.009473:0.004953:0.010911:0.007624
, :@0.848444:0.676966:0.857050:0.676966:0.857050:0.656593:0.848444:0.656593:0.004497:0.004109
which could be due to underlying biological factors or the efficiency of the crRNAs. We :@0.117647:0.697545:0.857057:0.697545:0.857057:0.677172:0.117647:0.677172:0.014792:0.011459:0.005547:0.008765:0.011459:0.004565:0.008994:0.010820:0.011550:0.005182:0.011391:0.004565:0.011251:0.009039:0.004565:0.011048:0.011345:0.009039:0.004565:0.006209:0.011048:0.004565:0.011413:0.011598:0.011322:0.009039:0.007599:0.005184:0.009724:0.005615:0.011459:0.009861:0.004565:0.010820:0.005547:0.010934:0.005182:0.011048:0.009861:0.005547:0.009108:0.009405:0.005250:0.004565:0.006209:0.009291:0.009108:0.006209:0.010843:0.007624:0.007670:0.004565:0.010843:0.007807:0.004565:0.006620:0.011299:0.009039:0.004565:0.009039:0.005692:0.005692:0.005623:0.008994:0.005547:0.009039:0.011596:0.009382:0.009724:0.004565:0.010845:0.006209:0.004565:0.006620:0.011302:0.009039:0.004565:0.008994:0.007807:0.013376:0.015408:0.014586:0.007670:0.004497:0.004565:0.018649:0.009039:0.004109
also observe differences in coverages at the cut sites within one locus (e.g. TRA), which :@0.117647:0.718123:0.857118:0.718123:0.857118:0.697750:0.117647:0.697750:0.009405:0.005250:0.007875:0.011048:0.004931:0.010957:0.010934:0.007873:0.009039:0.008400:0.009633:0.009039:0.004931:0.011391:0.005615:0.005969:0.005787:0.009039:0.007442:0.009039:0.011596:0.008994:0.009039:0.007670:0.004931:0.005615:0.011756:0.004931:0.008994:0.010866:0.009633:0.009039:0.007898:0.009199:0.009656:0.009039:0.007670:0.004931:0.008811:0.006437:0.004931:0.006620:0.011299:0.009039:0.004931:0.009108:0.011071:0.006437:0.004931:0.007601:0.005273:0.006209:0.009039:0.007670:0.004931:0.014723:0.005273:0.006620:0.011459:0.005615:0.011756:0.004931:0.010845:0.011596:0.009039:0.004931:0.005182:0.011274:0.009108:0.011413:0.007670:0.004931:0.006939:0.008743:0.004497:0.009679:0.004497:0.004931:0.013354:0.013650:0.014929:0.006939:0.004497:0.004931:0.014789:0.011459:0.005547:0.008768:0.011459:0.004109
would support a theory that crRNA efficiency drastically influences the enrichment ca-:@0.117647:0.738702:0.852941:0.738702:0.852941:0.718329:0.117647:0.718329:0.014518:0.010820:0.011550:0.005182:0.011391:0.004691:0.007510:0.011071:0.011048:0.011502:0.010843:0.007967:0.006437:0.004691:0.009291:0.004689:0.006620:0.011302:0.009106:0.010843:0.008400:0.009724:0.004691:0.006620:0.011391:0.008811:0.006437:0.004689:0.008994:0.007807:0.013376:0.015408:0.014929:0.004691:0.009039:0.005692:0.005692:0.005623:0.008994:0.005547:0.009039:0.011596:0.009382:0.009724:0.004689:0.011391:0.007898:0.009291:0.007510:0.006437:0.005547:0.009108:0.009405:0.005387:0.005182:0.009724:0.004689:0.005615:0.011756:0.005638:0.005296:0.011345:0.009039:0.011596:0.008994:0.009039:0.007670:0.004691:0.006620:0.011299:0.009039:0.004689:0.009039:0.011756:0.007807:0.005547:0.008765:0.011459:0.017485:0.009039:0.011391:0.006437:0.004691:0.009108:0.009291:0.007533
pabilities. However, investigating the relationship between coverage at the cut-site and :@0.117647:0.759281:0.857132:0.759281:0.857132:0.738908:0.117647:0.738908:0.011368:0.009108:0.010820:0.005752:0.005250:0.005271:0.006437:0.005549:0.009039:0.007670:0.004497:0.005718:0.016207:0.010866:0.014518:0.009336:0.009633:0.009039:0.006255:0.004497:0.005730:0.005615:0.011368:0.009633:0.009039:0.007510:0.006437:0.005615:0.009861:0.008811:0.006437:0.005615:0.011459:0.009861:0.005730:0.006620:0.011299:0.009039:0.005730:0.007442:0.008948:0.005433:0.008811:0.006437:0.005547:0.010843:0.011619:0.007556:0.011459:0.005273:0.011276:0.005730:0.011254:0.009131:0.006437:0.014518:0.009108:0.009039:0.011756:0.005730:0.008994:0.010866:0.009633:0.009039:0.007898:0.009199:0.009656:0.009039:0.005730:0.008811:0.006437:0.005730:0.006620:0.011299:0.009039:0.005730:0.009108:0.011071:0.006437:0.007533:0.007601:0.005273:0.006209:0.009039:0.005730:0.009085:0.011596:0.011391:0.004109
on/off-target scores of the crRNAs as provided by IDT , doesn’t show an obvious in-:@0.117647:0.779859:0.852941:0.779859:0.852941:0.759487:0.117647:0.759487:0.010843:0.011756:0.007099:0.010843:0.005969:0.005969:0.007533:0.006551:0.009085:0.007624:0.009656:0.009131:0.006437:0.005707:0.007875:0.008994:0.010843:0.007442:0.009039:0.007670:0.005707:0.010843:0.006209:0.005707:0.006620:0.011299:0.009039:0.005707:0.008994:0.007807:0.013376:0.015408:0.014586:0.007670:0.005707:0.009291:0.007670:0.005707:0.011071:0.007444:0.010863:0.009838:0.005549:0.011320:0.009108:0.011391:0.005707:0.010843:0.009724:0.005707:0.007259:0.015842:0.013354:0.018253:0.004497:0.005707:0.011322:0.011276:0.009039:0.007601:0.009587:0.003036:0.006437:0.005707:0.007556:0.011299:0.010866:0.014723:0.005707:0.009087:0.011756:0.005707:0.010957:0.010843:0.009838:0.005547:0.010820:0.011413:0.007670:0.005707:0.005615:0.011760:0.007533
408:@0.586084:0.772243:0.604329:0.772243:0.604329:0.760366:0.586084:0.760366:0.006082:0.006082:0.006082
fluence of crRNA efficiency on the coverage (:@0.117647:0.800438:0.506930:0.800438:0.506930:0.780065:0.117647:0.780065:0.005638:0.005296:0.011345:0.009039:0.011596:0.008994:0.009039:0.005661:0.010843:0.006209:0.005661:0.008994:0.007807:0.013376:0.015406:0.014929:0.005661:0.009039:0.005692:0.005692:0.005623:0.008994:0.005547:0.009039:0.011596:0.009382:0.009724:0.005661:0.010843:0.011756:0.005661:0.006620:0.011299:0.009039:0.005661:0.008994:0.010863:0.009635:0.009039:0.007896:0.009201:0.009653:0.009039:0.005661:0.006939
Supplementary Figure 3A and 3B:@0.506922:0.800438:0.808121:0.800438:0.808121:0.779305:0.506922:0.779305:0.010455:0.011893:0.011733:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.005524:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.005524:0.010911:0.015089:0.005524:0.009656:0.012167:0.011870:0.005524:0.010911:0.013765
). We :@0.808157:0.800438:0.857052:0.800438:0.857052:0.780065:0.808157:0.780065:0.006939:0.004497:0.005661:0.018649:0.009039:0.004109
do observe a correlation between sequencing throughput and coverage at the cut sites, :@0.117647:0.821017:0.857027:0.821017:0.857027:0.800644:0.117647:0.800644:0.011322:0.011048:0.005433:0.010957:0.010934:0.007875:0.009039:0.008398:0.009633:0.009039:0.005433:0.009291:0.005433:0.008994:0.010843:0.007807:0.007442:0.008948:0.005433:0.008811:0.006437:0.005547:0.010843:0.011756:0.005433:0.011254:0.009131:0.006437:0.014518:0.009108:0.009039:0.011756:0.005433:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.005433:0.006620:0.011459:0.007442:0.010820:0.011413:0.009930:0.011094:0.011048:0.011071:0.006437:0.005433:0.009085:0.011596:0.011391:0.005433:0.008994:0.010866:0.009633:0.009039:0.007898:0.009199:0.009656:0.009039:0.005433:0.008811:0.006437:0.005433:0.006617:0.011302:0.009039:0.005433:0.009108:0.011071:0.006437:0.005433:0.007601:0.005273:0.006209:0.009039:0.007670:0.004497:0.004109
indicating that a minimal sequencing throughput may be required for a successful en-:@0.117647:0.841596:0.852941:0.841596:0.852941:0.821223:0.117647:0.821223:0.005615:0.011596:0.011391:0.005547:0.009108:0.008811:0.006437:0.005615:0.011459:0.009861:0.005524:0.006620:0.011391:0.008811:0.006437:0.005524:0.009291:0.005524:0.017645:0.005615:0.011756:0.005615:0.017577:0.009405:0.005250:0.005524:0.007875:0.009106:0.010706:0.011345:0.009039:0.011598:0.008994:0.005615:0.011459:0.009861:0.005524:0.006617:0.011459:0.007444:0.010820:0.011413:0.009927:0.011094:0.011048:0.011071:0.006437:0.005524:0.017579:0.008925:0.009724:0.005524:0.011251:0.009039:0.005524:0.007442:0.009108:0.010703:0.011413:0.005615:0.007442:0.009108:0.011391:0.005524:0.006026:0.010843:0.007807:0.005524:0.009291:0.005524:0.007512:0.011345:0.008994:0.008994:0.009039:0.007533:0.007601:0.006366:0.011550:0.005250:0.005524:0.009039:0.011758:0.007533
richment (:@0.117647:0.862174:0.206626:0.862174:0.206626:0.841801:0.117647:0.841801:0.007807:0.005547:0.008765:0.011459:0.017485:0.009039:0.011391:0.006437:0.004109:0.006939
Supplementary Figure 3C:@0.206625:0.862174:0.435074:0.862174:0.435074:0.841041:0.206625:0.841041:0.010455:0.011893:0.011733:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.004018:0.011596:0.006209:0.010749:0.011893:0.008263:0.009473:0.004018:0.010911:0.014769
). :@0.435074:0.862174:0.450619:0.862174:0.450619:0.841801:0.435074:0.841801:0.006939:0.004497:0.004109
Taken together, these data show that we are able to comprehensively target fusion genes :@0.117647:0.882753:0.857144:0.882753:0.857144:0.862380:0.117647:0.862380:0.010911:0.009405:0.010272:0.009039:0.011756:0.004588:0.006209:0.011048:0.009656:0.009131:0.006620:0.011299:0.009039:0.006255:0.004497:0.004588:0.006617:0.011302:0.009039:0.007875:0.009039:0.004588:0.011573:0.008811:0.006551:0.009291:0.004588:0.007556:0.011299:0.010866:0.014723:0.004588:0.006620:0.011391:0.008811:0.006437:0.004588:0.014518:0.009039:0.004588:0.009085:0.007442:0.009039:0.004588:0.009108:0.010911:0.005182:0.009039:0.004588:0.006209:0.011048:0.004588:0.008994:0.010843:0.017280:0.011073:0.007442:0.008948:0.011299:0.009039:0.011619:0.007601:0.005547:0.009633:0.008948:0.005182:0.009724:0.004588:0.006551:0.009085:0.007624:0.009656:0.009131:0.006437:0.004588:0.006366:0.011413:0.007601:0.005547:0.010843:0.011756:0.004588:0.009656:0.009039:0.011596:0.009039:0.007670:0.004109
and Ig as well as TCR loci in one MinION sequencing run. With the tiled crRNA design :@0.117647:0.903332:0.857032:0.903332:0.857032:0.882959:0.117647:0.882959:0.009085:0.011596:0.011391:0.004177:0.006483:0.009861:0.004177:0.009291:0.007670:0.004177:0.014518:0.008948:0.005387:0.005250:0.004177:0.009291:0.007670:0.004177:0.013057:0.014678:0.013376:0.004177:0.005182:0.011276:0.008994:0.005615:0.004177:0.005615:0.011756:0.004177:0.010843:0.011598:0.009039:0.004177:0.019426:0.005615:0.011756:0.006825:0.016047:0.016230:0.004177:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.004177:0.007967:0.011413:0.011756:0.004497:0.004177:0.019951:0.005273:0.006620:0.011459:0.004177:0.006620:0.011299:0.009039:0.004177:0.006437:0.005752:0.005182:0.009108:0.011391:0.004177:0.008994:0.007807:0.013376:0.015408:0.014929:0.004177:0.011322:0.009039:0.007601:0.005615:0.009861:0.011756:0.004109